RP-54745
中文名称 | RP-54745 |
---|---|
中文同义词 | 化合物RP-54745;4-氯-5-(1-甲基-3,4-二氢异喹啉-2(1H)-基)-3H-1,2-二硫醇-3-酮 |
英文名称 | RP 54745 |
英文同义词 | RP 54745;4-chloro-5-(1-methyl-3,4-dihydro-1H-isoquinolin-2-yl)dithiol-3-one;3H-1,2-Dithiol-3-one, 4-chloro-5-(3,4-dihydro-1-methyl-2(1H)-isoquinolinyl)-;inhibit,RP-54745,RP 54745,Inhibitor,RP54745,Interleukin Related;4-Chloro-5-(1-methyl-3,4-dihydroisoquinolin-2(1H)-yl)-3H-1,2-dithiol-3-one |
CAS号 | 135330-08-4 |
分子式 | C13H12ClNOS2 |
分子量 | 297.82 |
EINECS号 | |
相关类别 | |
Mol文件 | 135330-08-4.mol |
结构式 |
RP-54745 性质
沸点 | 411.4±55.0 °C(Predicted) |
---|---|
密度 | 1.46±0.1 g/cm3(Predicted) |
储存条件 | under inert gas (nitrogen or Argon) at 2-8°C |
溶解度 | DMSO:62.5 mg/mL (209.86 mM);水:< 0.1 mg/mL(不溶) |
酸度系数(pKa) | -2.57±0.40(Predicted) |
形态 | 固体 |
颜色 | 浅黄至黄色 |
IL-1
|
RP-54745 diminishes LPS-induced interleukin-1 (IL-1) production by murine peritoneal macrophages.
RP-54745 (5 mg/kg) is effective at moderating oral doses in different mouse models of induced arthritis and in the MRL/lpr mice, genetically predisposed to develop an autoimmune pathology including arthritic disorders. The clinical status of the MRL mice, and several of their disturbed biochemical and immunological parameters, improved after a 3-month treatment with RP-54745.
安全信息
更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
---|---|---|---|---|---|
2024/08/19 | HY-101716 | RP-54745 RP-54745 | 135330-08-4 | 5mg | 1600元 |
2024/08/19 | HY-101716 | RP-54745 RP-54745 | 135330-08-4 | 10mg | 2560元 |